New medical and research park opens in south Chandler

Chandler Vice Mayor O.D. Harris, Council member Christine Ellis and many others attended the Sept. 19 ribbon cutting for ACT Medical Park.

The 28,000-square-foot medical facility is located near Pecos and McQueen roads. The grand opening event was meant to recognize a newer type of hybrid medical facility city leaders say is needed, according to a news release.

With Chandler approaching build-out and the population aging, redevelopment is a key for future growth, with medical offices as an area of opportunity.

The medical park’s first phase unit the ACT Imaging Center both claim to offer cutting-edge medical and research services.

The ACT Phase 1 Unit has 24 dedicated private rooms for clinical trial participants, a research pharmacy with USP 800 compounding capabilities, a research lab capable of complex processing, and a team of highly trained staff.

The unit’s patient database can support studies involving hepatic and renal impairments as well as healthy, matched patients. It can also accommodating people requiring hemodialysis.
ACT Imaging has specialized imaging technology for disease diagnostics and monitoring.

Construction of the park was not city-subsidized, though it did go through a Development Services permitting process.

The park also houses Arizona Liver Health, Arizona Clinical Trials, Phase 2-4 Trial Capabilities, VEN Centers, ALH|VEN Pharmacy, and the Arizona State Urological Institute.

Chandler Mayor Kevin Hartke praised the opening of the facility and the people who articulated the need to locate it in Chandler and made it happen.
Dr. Anita Kohli, CEO of Arizona Liver Health/Arizona Clinical Trials, said, in a news release, providing cutting-edge treatments and diagnostics is not only essential to Chandler, but to the Arizona community in general.

“We look forward to the transformative impact this facility will have on the lives of our patients and the broader healthcare landscape,” she said.

We invite our readers to submit their civil comments on this topic.  Email AZOpinions@iniusa.org .